ARX vs ERIE: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: ARX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ARX and ERIE share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ARX and ERIE exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Accelerant Holdings operates a data-driven risk exchange for specialty insurance. On one side are managing general agents (MGAs), the specialist underwriters who design and sell niche insurance products; on the other are risk capital partners such as insurers, reinsurers, and institutional investors who put up the capital to back those policies. Accelerant sits in the middle, using proprietary technology, data, and machine learning to match risk with capital, share high-fidelity underwriting data, and monitor portfolios. It earns a fixed-percentage, volume-based fee for sourcing, managing, and monitoring the business written through the exchange, which spans more than 500 specialty insurance products across 22 countries. The company reports through three segments: Exchange Services, MGA Operations, and Underwriting, and describes its model as capital-light because it aims to retain only a small share of the premium risk (roughly 9% in 2025) and pass the rest to third-party capital.

Full ARX guide

Erie Indemnity is the managing attorney-in-fact for the Erie Insurance Exchange, a reciprocal insurer owned by its policyholders. Rather than underwriting risk itself, Erie Indemnity provides sales, underwriting, policy issuance, billing, and administrative services to the Exchange and is paid a management fee set at up to 25 percent of the direct and affiliated assumed premiums the Exchange writes. This structure gives shareholders exposure to the growth of a large property, casualty, and life book across the eastern and midwestern United States without bearing the catastrophe and underwriting losses that sit inside the Exchange itself.

Full ERIE guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ARX drivers: Growing the exchange network; The capital-light shift.
• ERIE drivers: Fee growth tied to Exchange premiums; Capital-light, high-margin model.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The dominant uncertainty is that the capital-light model is young and unproven across a full insurance cycle. For ERIE, erie Indemnity is almost entirely dependent on a single client, the Erie Insurance Exchange, so any deterioration in the Exchange's underwriting results, financial strength, or premium growth flows through to the management fee and dividend capacity.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ARX if you believe its drivers more; ERIE if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ARX and ERIE guides.

ARX. Figures are approximate and tied to the asOf date; verify live numbers before acting. Because Accelerant only listed in July 2025, its trading and reporting history is short, and its large statutory net loss diverges from the adjusted EBITDA it emphasizes, so the two frames tell different stories. The valuation reflects rapid revenue and EBITDA growth rather than current bottom-line profit, meaning the figures matter most as a gauge of how much future growth is already priced in.

ERIE. Erie Indemnity trades at a premium price-to-earnings multiple, roughly 19 to 21 times earnings, well above the broader property and casualty average, reflecting the market paying up for a stable fee-based model. That premium has compressed from ERIE's own multi-year highs as premium growth slowed to the mid-single digits and policy counts slipped. Net income and operating income rose year over year in Q1 2026 on higher management fee and investment income.

Headline figures (approximate, July 2026): ARX shows exchange written premium (fy 2025) ~$4.19 billion, up ~35% year over year, revenue (fy 2025 / q1 2026) ~$913 million FY 2025; ~$273 million in Q1 2026 (up ~54%), adjusted ebitda ~$282 million FY 2025; ~$66 million in Q1 2026 (up ~69%), net income (fy 2025) ~$1.35 billion loss, almost all from a ~$1.38 billion non-cash IPO item; ERIE shows revenue (ttm) ~$4.1B, q1 2026 operating revenue ~$1.01B, q1 2026 net income ~$150M, q1 2026 diluted eps ~$2.88.

ARX and ERIE are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ARX and ERIE exposure against your real portfolio. It is not an investment adviser.